Stockreport

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting [Yahoo! Finance]

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF These data will further add to the already strong clinical data package for EVX-01 The trial remains on track for two-year clinical efficacy data readout in the secon [Read more]